GREENBERG TRAURIG, LLP for SI GROUP CLIENT SERVICES
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Tobacco TOB
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor administrative and legislative action related to: -Marketing and advertising of tobacco products; -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act; -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) - FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065) Outreach and monitoring related to the following: -S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. -S. 655 / H.R. 1498, SAFE Kids Act. -S. 1253 / H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act. -S. 1541, Tobacco-Free Youth Act. -S. 2517, Tobacco Tax Equity Act of 2019 -S. 2463, E-Cigarette Tax Parity Act -H.R. 4742, Protecting American Lungs Act of 2019 -H.R. 2339, Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT MAPLES | — |
| K LAURIE MCKAY | — |
| KATIE PHILLIPS REED | — |
| L ANDREW ZAUSNER | — |
Health Issues HCR
Congressional outreach and monitoring related to the tobacco industry. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor administrative and legislative action related to: -Marketing and advertising of tobacco products; -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act; -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) - FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065) Outreach and monitoring related to the following: -S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. -S. 655 / H.R. 1498, SAFE Kids Act. -S. 1253 / H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act. -S. 1541, Tobacco-Free Youth Act. -S. 2517, Tobacco Tax Equity Act of 2019 -S. 2463, E-Cigarette Tax Parity Act -H.R. 4742, Protecting American Lungs Act of 2019 -H.R. 2339, Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT MAPLES | — |
| K LAURIE MCKAY | — |
| KATIE PHILLIPS REED | — |
| L ANDREW ZAUSNER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.